Literature DB >> 22341034

Diabetes, hyperglycaemia, and acute ischaemic stroke.

Merel J A Luitse1, Geert Jan Biessels, Guy E H M Rutten, L Jaap Kappelle.   

Abstract

Diabetes and ischaemic stroke often arise together. People with diabetes have more than double the risk of ischaemic stroke after correction for other risk factors, relative to individuals without diabetes. Multifactorial treatment of risk factors for stroke-in particular, lifestyle factors, hypertension, and dyslipidaemia-will prevent a substantial number of these disabling strokes. Hyperglycaemia occurs in 30-40% of patients with acute ischaemic stroke, also in individuals without a known history of diabetes. Admission hyperglycaemia is associated with poor functional outcome, possibly through aggravation of ischaemic damage by disturbing recanalisation and increasing reperfusion injury. Uncertainty surrounds the question of whether glucose-lowering treatment for early stroke can improve clinical outcome. Achievement of normoglycaemia in the early stage of stroke can be difficult, and the possibility of hypoglycaemia remains a concern. Phase 3 studies of glucose-lowering therapy in acute ischaemic stroke are underway. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22341034     DOI: 10.1016/S1474-4422(12)70005-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  134 in total

1.  New developments in clinical ischemic stroke prevention and treatment and their imaging implications.

Authors:  Jeremy J Heit; Max Wintermark
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-14       Impact factor: 6.200

2.  Elevated Expression of Carboxy-Terminal Modulator Protein (CTMP) Aggravates Brain Ischemic Injury in Diabetic db/db Mice.

Authors:  Yu Chen; Min Cai; Jiao Deng; Li Tian; Shiquan Wang; Li Tong; Hailong Dong; Lize Xiong
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

Review 3.  Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

Authors:  Cristina Barsanti; Francesca Lenzarini; Claudia Kusmic
Journal:  World J Diabetes       Date:  2015-06-25

4.  The pleiotropic effect of rs7903146 on type 2 diabetes and ischemic stroke: a family-based study in a Chinese population.

Authors:  Jing Song; Yiqun Wu; Juan Juan; Yaying Cao; Tao Wu; Yonghua Hu
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

5.  Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet.

Authors:  Maria Chomova; Maria Balazova; Jana Muchova
Journal:  Mol Cell Biochem       Date:  2017-05-19       Impact factor: 3.396

6.  Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study.

Authors:  Brenna Cholerton; Adam Omidpanah; Steven P Verney; Lonnie A Nelson; Laura D Baker; Astrid Suchy-Dicey; William T Longstreth; Barbara V Howard; Jeffrey A Henderson; Thomas J Montine; Dedra Buchwald
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-15       Impact factor: 3.485

7.  Chikusetsu Saponin IVa Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice via Adiponectin-Mediated AMPK/GSK-3β Pathway In Vivo and In Vitro.

Authors:  Jialin Duan; Ying Yin; Jia Cui; Jiajia Yan; Yanrong Zhu; Yue Guan; Guo Wei; Yan Weng; Xiaoxiao Wu; Chao Guo; Yanhua Wang; Miaomiao Xi; Aidong Wen
Journal:  Mol Neurobiol       Date:  2015-01-31       Impact factor: 5.590

8.  Cervical arteriosclerosis is associated with preoperative clinical symptoms in patients with cervical spondylotic myelopathy.

Authors:  Gentaro Kumagai; Kanichiro Wada; Sunao Tanaka; Toru Asari; Yasuyuki Ishibashi
Journal:  Eur Spine J       Date:  2020-11-09       Impact factor: 3.134

9.  Effect of Stress-free Therapy on Cerebral Blood Flow: Comparisons among patients with metabolic cardiovascular disease, healthy subjects and placebo-treated subjects.

Authors:  Kenji Ryotokuji; Keisou Ishimaru; Kazuhiko Kihara; Yoshihisa Namiki; Takuma Nakashima; Satoru Otani
Journal:  Laser Ther       Date:  2014-03-27

10.  Complement Component C3 Promotes Cerebral Ischemia/Reperfusion Injury Mediated by TLR2/NFκB Activation in Diabetic Mice.

Authors:  Zheng Lin; Haoran Lin; Wenlu Li; Yuwen Huang; Haibin Dai
Journal:  Neurochem Res       Date:  2018-06-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.